Welcome

We are delighted to invite you to the 2025 Asian Federation for Pharmaceutical Sciences (AFPS) Conference from 3 to 5 December 2025 in Sydney. 

This conference will unite pharmaceutical scientists, researchers, and industry leaders from across Asia and beyond for three days of innovation, collaboration, and knowledge exchange.

One Health – Unifying Science, Innovation, and Humanity for a Sustainable Future’

Our conference theme reflects the critical intersection of health, environmental sustainability, and technological advancement. Through the central message of ‘Unifying Medicine, Nature, and Technology,’ we aim to foster meaningful dialogue and inspire solutions to today’s most pressing health challenges.

Why attend AFPS 2025?

  • Access cutting-edge pharmaceutical research and insights from industry leaders, regulatory bodies, and academia through keynote talks, panel discussions, and poster sessions
  • Experience live demonstrations of innovative technologies including AI-driven drug discovery, precision medicine tools, and digital therapeutics
  • Enhance your expertise through hands-on workshops and specialised training in laboratory techniques, regulatory compliance, and data analytics
  • Build valuable connections with international researchers, industry partners, and collaborators through mentoring sessions and themed networking events
  • Contribute to discussions on critical topics like bio convergence, sustainable manufacturing, and the future of pharmacy education
  • Participate in innovation challenges and collaborative problem-solving sessions focused on real-world pharmaceutical industry challenges

We look forward to welcoming you to Sydney for what promises to be an inspiring and rewarding event.

Prof Wojciech Chrzanowski
Co-chair
Prof Lee Yong Lim
Co-chair
Dr Philip Kwok
Co-chair
Prof Andrew McLachlan
Chief Patron

Plenary speakers

Dr Kimberly Homan

Dr George Leung

Invited speakers

RR MedScience

Industrial Partner

Taron Solutions

Industrial Partner

Craft Health

Industrial Partner

Genomic medicine and personalised therapies
  • Advances in genomics, gene editing, and precision medicine.
  • Ethical/legal considerations and regulatory challenges.
  • Nuclear science in pharmaceutical and medical sciences
Non-animal innovation and alternative testing methods
  • Advancements in in vitro models, organoids, and computational simulations.
  • 3Rs and cruelty-free research and development.
Nano-pharmacy and drug delivery systems
    • Nanotechnology applications in drug formulation and targeted delivery.
    • Extracellular vesicles as drug delivery vectors and adjuvants.
    • Safety, efficacy, and scalability.
Antimicrobial Resistance (AMR) – global innovations and strategies to overcome AMR: a call to action!
    • Next-generation antimicrobials.
    • Alternative therapies such as bacteriophage-based treatments, CRISPR-Cas antimicrobials, and microbiome-derived agents
    • One health approaches to AMR
    • Regulatory policies and stewardship programs.
3D Printing technology and personalised medicines 
    • Innovations in 3D printing for the pharmaceutical industry.
    • Regulatory considerations in 3D printed pharmaceuticals.
    • Clinical applications and case studies of 3D printed drugs.
AI-driven pharmacy solutions
    • AI for drug discovery, patient care, and supply chain optimization.
    • Ethical implications and data privacy.
Self-driving pharmaceutical laboratories
  • Autonomous labs for sample processing, quality control, and inventory management.
  • Safety protocols and cost-effectiveness.
Industry-pharmacy partnerships for innovation
  • Collaboration between pharmaceutical companies and research institutions.
  • Success stories and best practices.
Digital and hospital pharmacy excellence
    • Hospital drug management, patient safety, and clinical pharmacy.
    • Interdisciplinary teamwork.
    • Medicine without Meds – transforming Patient Care with Digital Therapies
Age-appropriate paediatric formulations
  • Inaugural forum for an Asian Paediatric Formulation Initiative
  • Development and evaluation of age-appropriate paediatric formulations 
  • Taste-masking strategies for paediatric formulations
Cannabis-based medicines, psychedelics and alternative medicine integration
  • Evidence-based herbal medicine, traditional practices, and holistic approaches – indigenous medicines.
  • Synergies with pharmaceuticals.
Mechanopharmacology and mechanobiology
  • Mechanopharmacology in drug discovery.
  • Mechanobiology as a biomarker in drug development and testing.

Conference themes

The HERDSA 2023 Organising Committee

Name

Conference
Co-Convenor

details if needed

Name

Conference
Co-Convenor

details if needed

Name

Conference
Co-Convenor

details if needed